Compuestos de dosis fija en la prevención secundaria de la cardiopatía isquémica-Reference-Cited by-同舟云学术

Compuestos de dosis fija en la prevención secundaria de la cardiopatía isquémica

Published:2011-07 Issue: Volume:64 Page:3-9
ISSN:0300-8932
Container-title:Revista Española de Cardiología
language:es
Short-container-title:Revista Española de Cardiología

Author:

Fuster Valentín,Sanz Ginés

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Heart Protection Study Collaborative roup;Collins;MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet.,2003

2. Two decades of progress in preventing vascular disease;Yusuf;Lancet.,2002

3. A strategy to reduce cardiovascular disease by more than 80%;Wald;BMJ.,2003

4. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis;Hippisley-Cox;BMJ.,2005

5. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials;Dagenais;Lancet.,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain;International Journal of Cardiology;2019-10

2. Documento de consenso del uso clínico de la Polypill en la prevención secundaria del riesgo cardiovascular;Medicina Clínica;2017-02

3. Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease;Medicina Clínica (English Edition);2017-02

4. Terapia con fibratos: uso racional del fenofibrato 2016. Resumen ejecutivo;Clínica e Investigación en Arteriosclerosis;2016-11

5. Parte II. Combinación de estatina más fibrato (libre y fija);Clínica e Investigación en Arteriosclerosis;2016-07